Status:
COMPLETED
Once Weekly Subcutaneous Ports for the Administration of Anticoagulants
Lead Sponsor:
University of North Carolina, Chapel Hill
Collaborating Sponsors:
IntraPump Infusion Systems
Laboratory Corporation of America
Conditions:
Venous Thromboembolism
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to ascertain whether subcutaneous ports are an effective and reliable way to administer the low molecular weight heparin (LMWH) enoxaparin to patients for the prevention o...
Detailed Description
Subcutaneous ports have recently been used to administer Low Molecular Weight Heparin (LMWH) to patients for the prevention or treatment of venous thromboembolism; however, no studies have been perfor...
Eligibility Criteria
Inclusion
- Subjects receiving once or twice daily dosing of therapeutic doses of subcutaneous Enoxaparin.
- Subject has been on the same dose of Enoxaparin for at least one week.
- Anticipated length of Enoxaparin treatment at least 4 weeks.
- Age ≥ 18 years.
- Subject demonstration of proper subcutaneous catheter care during one education session with the investigator.
Exclusion
- Chronic renal insufficiency with glomerular filtration rate \< 30 mL/min.
- Pregnancy
- Venous thromboembolism within the last 4 weeks.
Key Trial Info
Start Date :
August 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2010
Estimated Enrollment :
21 Patients enrolled
Trial Details
Trial ID
NCT00774748
Start Date
August 1 2008
End Date
April 1 2010
Last Update
May 23 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of North Carolina at Chapel Hill School of Medicine; University of North Carolina Hospital, N.C. Memorial Hospital
Chapel Hill, North Carolina, United States, 27514